Robust Revascularization in Models of Limb Ischemia Using a Clinically Translatable Human Stem Cell-Derived Endothelial Cell Product

Pluripotent stem cell-derived differentiated endothelial cells offer high potential in regenerative medicine in the cardiovascular system. With the aim of translating the use of a human stem cell-derived endothelial cell product (hESC-ECP) for treatment of critical limb ischemia (CLI) in man, we rep...

Descripción completa

Detalles Bibliográficos
Autores principales: MacAskill, Mark G., Saif, Jaimy, Condie, Alison, Jansen, Maurits A., MacGillivray, Thomas J., Tavares, Adriana A.S., Fleisinger, Lucija, Spencer, Helen L., Besnier, Marie, Martin, Ernesto, Biglino, Giovanni, Newby, David E., Hadoke, Patrick W.F., Mountford, Joanne C., Emanueli, Costanza, Baker, Andrew H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035339/
https://www.ncbi.nlm.nih.gov/pubmed/29703701
http://dx.doi.org/10.1016/j.ymthe.2018.03.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035339/
https://www.ncbi.nlm.nih.gov/pubmed/29703701
http://dx.doi.org/10.1016/j.ymthe.2018.03.017

Ejemplares similares